Two recent developments in artificial intelligence (AI) and machine learning have the potential to accelerate product development by streamlining materials research. Israel-based MaterialsZone, a ...
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback